WB
The startup specializes in liquid biopsy technology for cancer profiling through blood analysis, enabling early detection and personalized treatment strategies. This approach allows clinicians to assess tumor dynamics and predict patient outcomes with greater accuracy, improving patient management in oncology.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in liquid biopsy technology for cancer profiling through blood analysis, enabling early detection and personalized treatment strategies. This approach allows clinicians to assess tumor dynamics and predict patient outcomes with greater accuracy, improving patient management in oncology.